These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39139778)

  • 21. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
    Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
    Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
    [No Abstract]   [Full Text] [Related]  

  • 22. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
    Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
    Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting.
    Morgan JR; Barocas JA; Murphy SM; Epstein RL; Stein MD; Schackman BR; Walley AY; Linas BP
    JAMA Netw Open; 2020 Dec; 3(12):e2029676. PubMed ID: 33320266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
    Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
    J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projected Estimates of Opioid Mortality After Community-Level Interventions.
    Linas BP; Savinkina A; Madushani RWMA; Wang J; Eftekhari Yazdi G; Chatterjee A; Walley AY; Morgan JR; Epstein RL; Assoumou SA; Murphy SM; Schackman BR; Chrysanthopoulou SA; White LF; Barocas JA
    JAMA Netw Open; 2021 Feb; 4(2):e2037259. PubMed ID: 33587136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study.
    Macmadu A; Adams JW; Bessey SE; Brinkley-Rubinstein L; Martin RA; Clarke JG; Green TC; Rich JD; Marshall BDL
    Int J Drug Policy; 2021 May; 91():102841. PubMed ID: 32712165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Opioid Epidemic Blunted the Mortality Benefit of Medicaid Expansion.
    Yan BW; Sloan FA; Boscardin WJ; Guo F; Dudley RA
    Med Care Res Rev; 2021 Apr; 78(2):103-112. PubMed ID: 32403982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.
    Johnson K; Hills H; Ma J; Brown CH; McGovern M
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):220-228. PubMed ID: 33054435
    [No Abstract]   [Full Text] [Related]  

  • 31. The Role of Primary Care in the Initiation of Opioid Use Disorder Treatment in Statewide Public and Private Insurance.
    Gertner AK; Rotter JS; Holly ME; Shea CM; Green SL; Domino ME
    J Addict Med; 2022 Mar-Apr 01; 16(2):183-191. PubMed ID: 33973922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose.
    Treitler P; Crystal S; Cantor J; Chakravarty S; Kline A; Morton C; Powell KG; Borys S; Cooperman NA
    JAMA Netw Open; 2024 Mar; 7(3):e243614. PubMed ID: 38526490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities in opioid use disorder-related hospital use among postpartum Virginia Medicaid members.
    Martin CE; Britton E; Shadowen H; Bachireddy C; Harrell A; Zhao X; Cunningham P
    J Subst Use Addict Treat; 2023 Feb; 145():208935. PubMed ID: 36880911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.
    Goyal S; Monsour M; Ko JY; Curtis KM; Whiteman MK; Coy KC; Cox S; Romero L
    Contraception; 2023 Jan; 117():67-72. PubMed ID: 36243128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes.
    Banta-Green CJ; Owens MD; Williams JR; Floyd AS; Williams-Gilbert W; Kingston S
    Subst Abuse Rehabil; 2024; 15():173-183. PubMed ID: 39295965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medications For Opioid Use Disorder Increased Among Louisiana Medicaid Enrollees During Policy Reforms, 2018-21.
    Sugarman OK; Li W; Saloner B
    Health Aff (Millwood); 2024 Jan; 43(1):46-54. PubMed ID: 38190602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations Between Copays, Coverage Limits for Opioid Use Disorder Medications, and Prescribing in Medicaid, 2018.
    Barenie RE; Kesselheim AS; Tsacogianis T; Fischer MA
    Med Care; 2021 Mar; 59(3):266-272. PubMed ID: 33560766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study.
    Treitler P; Enich M; Bowden C; Mahone A; Lloyd J; Crystal S
    J Subst Use Addict Treat; 2024 Jan; 156():209212. PubMed ID: 37935350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.
    Krawczyk N; Lim S; Cherian T; Goldfeld KS; Katyal M; Rivera BD; McDonald R; Khan M; Wiewel E; Braunstein S; Murphy SM; Jalali A; Jeng PJ; Kutscher E; Khatri UG; Rosner Z; Vail WL; MacDonald R; Lee JD
    Drug Alcohol Depend; 2024 Aug; 261():111377. PubMed ID: 38924958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicaid Expansion and Mortality Among Persons Who Were Formerly Incarcerated.
    Perera PS; Miller VE; Fitch KV; Swilley-Martinez ME; Rosen DL; Brinkley-Rubinstein L; Marshall BDL; Pence BW; Kavee AL; Proescholdbell SK; Martin RA; Peiper LJ; Ranapurwala SI
    JAMA Netw Open; 2024 Sep; 7(9):e2429454. PubMed ID: 39287949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.